These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9229566)
1. [Fatty liver hepatitis]. Seidler D Dtsch Med Wochenschr; 1997 Jun; 122(24):802-3. PubMed ID: 9229566 [No Abstract] [Full Text] [Related]
2. [Plasma levels of ceruloplasmin and copper in children with hepatic damage]. Larrain F; Urbina AM; Lorenzo C; Danus O Rev Chil Pediatr; 1975; 46(4):351-5. PubMed ID: 1233556 [No Abstract] [Full Text] [Related]
3. [Hepatolenticular degeneration and hepatocerebral syndromes]. Martynov IuS; Malkova EV Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(1):53-7. PubMed ID: 4747508 [No Abstract] [Full Text] [Related]
4. Wilson disease. Houwen RH; van Hattum J; Hoogenraad TU Neth J Med; 1993 Aug; 43(1-2):26-37. PubMed ID: 8232692 [No Abstract] [Full Text] [Related]
5. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration]. Pakszys W; Ligezińska B; Szymański H Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091 [No Abstract] [Full Text] [Related]
6. Wilson's disease patients with normal ceruloplasmin levels. Yüce A; Koçak N; Ozen H; Gürakan F Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and differential diagnosis of hepatocerebral degeneration (Westphal-Strümpell-Wilson disease)]. Bachmann H; Biesold D; Eichner B; Günther K; Lössner J; Weise H; Willgerodt H Z Arztl Fortbild (Jena); 1972 Jul; 66(13):670-4. PubMed ID: 4636967 [No Abstract] [Full Text] [Related]
8. [Ceruloplasmin in chronic liver diseases]. Mardare G; Strat C; Drăgan M; Terek C; Pandele G; Boingeanu A Med Interna (Bucur); 1973 Feb; 25(2):229-36. PubMed ID: 4793927 [No Abstract] [Full Text] [Related]
9. Westphal-Strümpell disease: a case report with a new method of urinary copper evaluation. Stefanini MC; Altavista MC; Carelli G Ital J Neurol Sci; 1983 Jun; 4(2):197-202. PubMed ID: 6618857 [TBL] [Abstract][Full Text] [Related]
10. Penicillamine-induced cupriuria in normal subjects and in patients with active liver disease. Lynch RE; Lee GR; Cartwright GE Proc Soc Exp Biol Med; 1973 Jan; 142(1):128-30. PubMed ID: 4683230 [No Abstract] [Full Text] [Related]
12. Serum 'free' copper in Wilson disease. Walshe JM QJM; 2012 May; 105(5):419-23. PubMed ID: 22139498 [TBL] [Abstract][Full Text] [Related]
13. [Determination of copper in serum and urine of hepatolenticular degeneration patient and their clinic meaning]. Deng SL; Li XF; Guo XL Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Jun; 23(3):576-8. PubMed ID: 12953546 [TBL] [Abstract][Full Text] [Related]
14. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin. Wald I; Galewicz A; Górska D Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986 [No Abstract] [Full Text] [Related]
16. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease. Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731 [TBL] [Abstract][Full Text] [Related]
17. [The clinical characteristics and differential diagnosis of hyperkinetic forms of multiple sclerosis]. Chernigovskaia NV Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):23-7. PubMed ID: 5425793 [No Abstract] [Full Text] [Related]
18. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin]. Wald I; Galewicz A; Górska D Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660 [No Abstract] [Full Text] [Related]
19. Serum ceruloplasmin levels in healthy persons and in certain pathologic conditions. Lyko J Acta Med Pol; 1967; 8(3):269-77. PubMed ID: 6062192 [No Abstract] [Full Text] [Related]